WBUR reports One-Person Drug Companies Sprouting Up In Boston.
"Dennis Goldberg runs a drug company out of one corner of his living room...The drug he and a couple of investors are putting through human trials right now is a cholesterol drug, an improvement over Lipitor. But Goldberg said he doesn’t need to have a corporate headquarters in Cambridge for LipimetiX to be successful. What Goldberg does is simply contract out the work he needs to get done. A peptide manufacturer makes the drug for him. Then he hires a lab to research it and then contracts with medical clinics to do the drug trials. Goldberg is spending $6 million of his and investor money to take this cholesterol drug through the first set of human trials."
No comments:
Post a Comment